Statement from Claude Lenfant, M.D., NHLBI Director, on Trends in Hypertension

New information gathered by the National Heart, Lung, and Blood Institute's Framingham Heart Study, and reported in the April 22 New England Journal of Medicine, indicates that a five- to tenfold increase in use of antihypertensive medication from the 1950s through the 1980s was accompanied by striking declines in the prevalence of the highest blood pressure levels (3 and 4) down to more moderate levels (1 and 2). High blood pressure at stage 3 is systolic blood pressure of 180 to 209 mm Hg or diastolic blood pressure of 110 to 119 mm Hg. Stage 4 high blood pressure is systolic blood pressure of at least 210 mm Hg or diastolic blood pressure of at least 120 mm Hg. The study further notes that the favorable trends in hypertension treatment and control were accompanied by a decline in hypertensive target organ damage in the form of left ventricular hypertrophy (LVH), which is an important risk factor for both cardiovascular disease and fatal coronary heart disease.

Despite this encouraging news, however, it is important to note that the majority of coronary heart disease and stroke occurs at lower stages of hypertension. And, although hypertension levels declined over the 4 decades between 1950 and 1989, recent data from the National Health and Nutrition Examination Survey (NHANES) reveal that a national downward trend in blood pressure control rates slowed in the 1990s and actually headed slightly higher. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI), which NHLBI released in November 1997, reported this disturbing trend.

JNC VI also noted a slight rise in the rate of stroke, increases in both end-stage renal disease and heart failure, and a leveling in the death rate for people with coronary heart disease. These indicators signal the clear need for physicians and patients to redouble efforts to prevent and treat hypertension.

The JNC VI guidelines urge a populati

Contact: NHLBI Communications Office
NIH/National Heart, Lung, and Blood Institute

Page: 1 2

Related medicine news :

1. Statement on the findings of the Womens Health Study
2. Statement: Implantable medical identification chip
3. Statement from Barbara Alving of NHLBI on guidelines for cardiovascular disease prevention in women
4. Statement from Spondylitis Association of America
5. Statement by Dr. Colwell on Nobel Prizes in Science and NSF onnection
6. The CARDIA Study: Statement from Dr. Claude Lenfant, director, National Heart, Lung, and Blood Institute
7. Statement from Dr. Claude Lenfant, director, NHLBI and Dr. Phillip Gorden, director, NIDDK
8. Dental Researchers Retract Statement Indicating Hydrogen Peroxide May Be Cancer Promoter
9. Jeffrey S. Flier, M.D., elected to Institute of Medicine
10. UCSDs Victor Nizet, M.D., receives Pediatric Infectious Diseases Award
11. William Cohn, M.D., of Beth Israel Deaconess Medical Center, receives the 2000 Distinguished Inventor Award

Post Your Comments:

(Date:8/14/2018)... ... August 14, 2018 , ... Health & hygiene ... Report , which is the largest study of brands based on emotions. In the ... in the Top 10 for the health & hygiene industry were: Listerine, Nivea, Gillette, ...
(Date:8/11/2018)... ... August 10, 2018 , ... TopConsumerReviews.com recently ... , What is gout? This painful, persistent condition originates in the liver and ... levels of uric acid. Other contributing factors may be medication side effects, overweight, ...
(Date:8/9/2018)... (PRWEB) , ... August 09, 2018 , ... Lyme disease ... reported per year skyrocketing to an estimated 329,000 – a 25-fold increase since surveillance ... , Lyme disease can be found all 50 states and the District of Columbia. ...
(Date:8/7/2018)... ... August 07, 2018 , ... Josh Sprague, Founder and CEO ... video preview for the upcoming Leadville 100 MTB. , Accompanied by colleague Marvin ... what he has called “one of the most iconic mountain bike race courses in ...
(Date:8/3/2018)... ... ... On August 2, 2018 the JPML ordered that the Zostavax MDL be assigned ... been litigating Zostavax injuries since 2011. , On July ... thousands of people injured by Zostavax, a vaccine given to adults to prevent shingles. ...
Breaking Medicine News(10 mins):
(Date:8/9/2018)... ... August 09, 2018 , ... National Day ... cbdMD named the exclusive sponsor. , “We’re honored to have been selected as ... embrace for CBD on a national level,” said cbdMD’s Chief Scientific Officer, Dr. ...
(Date:8/7/2018)... ... 07, 2018 , ... Penn State graduate, Dr. Kevin Pauza, ... begun training and certifying spine physicians across the United States on his technique ... at the Weill Cornell Brain and Spine Center in July, and have begun ...
(Date:8/3/2018)... (PRWEB) , ... August 03, 2018 , ... Flexefits, a ... passing H.R. 6199, especially for its allowing participants in Direct Primary Care arrangements to ... by HSAs (capped at $150 per individual and $300 per family per month.) , ...
Breaking Medicine Technology:
Cached News: